Esperion Therapeutics
ESPR
#7604
Rank
A$0.47 B
Marketcap
$2.40
Share price
1.34%
Change (1 day)
-27.22%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.23

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.46. In 2022 the company made an earnings per share (EPS) of -$5.62 an increase over its 2021 EPS that were of -$15.13.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.23-24.66%
2022-$5.62-62.87%
2021-$15.1380.38%
2020-$8.3950.14%
2019-$5.59-53.18%
2018-$11.937.41%
2017-$11.11110.81%
2016-$5.2747.35%
2015-$3.580.89%
2014-$3.5428.84%
2013-$2.75-89.3%
2012-$25.71
2002-$10.838.89%
2001-$9.95-83.77%
2000-$61.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$16.20 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.23-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.94-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$59.11-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.01-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.08-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA